(secondQuint)ARBITER-II: Aorfix Bifurcated Safety and Performance Trial: Phase II, Angulated Vessels.

 The Aorfix cent Stent Graft is currently a CE-marked product indicated for AAA where the angle of the aneurysm is cent Stent Graft in the treatment of infrarenal abdominal aortic aneurysms and aorto-iliac aneurysms, in infrarenal necks angulated > 60o (between 60 to 90 degrees) as measured by 3-dimensional reconstruction in order to widen the indication.

 The investigation is a prospective open label, single arm, multi-centre clinical study.

 The study group will consist of 25 evaluable participants.

 In order to account for patients lost to follow up (estimated at approximately 20%) up to 30 patients will be enrolled in the study.

.

 ARBITER-II: Aorfix Bifurcated Safety and Performance Trial: Phase II, Angulated Vessels@highlight

To assess the safety and performance of Aorfix cent Stent Grafts in the treatment of Abdominal Aortic and Aorto-Iliac Aneurysm where a significant degree of vessel angulation exists at the neck of the aneurysm or in the common iliac arteries.

